Loading ETF profile…
The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. The fund is designed to capitalize on innovation in treatments for CNS diseases.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS, INC. | 10.33% | $1.06M |
| REGN | REGENERON PHARMACEUTICALS, INC. | 8.09% | $831.60K |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 7.74% | $796.37K |
| ARGX | ARGENX SE | 5.83% | $599.68K |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | 4.89% | $503.26K |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD. | 4.32% | $443.88K |
| LLY | ELI LILLY & CO. | 4.05% | $416.99K |
| CRNX | CRINETICS PHARMACEUTICALS, INC. | 3.54% | $363.76K |
| IONS | IONIS PHARMACEUTICALS, INC. | 3.48% | $357.92K |
| SYK | STRYKER CORP. | 3.22% | $331.32K |
| BIIB | BIOGEN, INC. | 3.21% | $330.01K |
| MDT | MEDTRONIC PLC | 2.59% | $265.88K |
| UCB.BR | UCB SA | 2.48% | $255.14K |
| ACAD | ACADIA PHARMACEUTICALS, INC. | 2.42% | $249.32K |
| CPRX | CATALYST PHARMACEUTICALS, INC. | 2.33% | $239.75K |
| AXSM | AXSOME THERAPEUTICS, INC. | 2.33% | $239.73K |
| — | CASH & CASH EQUIVALENTS | 2.08% | $213.81K |
| DNLI | DENALI THERAPEUTICS, INC. | 1.98% | $203.94K |
| RNA | AVIDITY BIOSCIENCES, INC. | 1.88% | $193.68K |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1.88% | $193.15K |
| XENE | XENON PHARMACEUTICALS, INC. | 1.81% | $186.39K |
| DXCM | DEXCOM, INC. | 1.72% | $176.87K |
| SRRK | SCHOLAR ROCK HOLDING CORP. | 1.71% | $175.84K |
| PTCT | PTC THERAPEUTICS, INC. | 1.58% | $162.85K |
| ALKS | ALKERMES PLC | 1.53% | $157.71K |